glucagon receptor agonist
Jump to navigation
Jump to search
Indications
- treatment of diabetes mellitus type-2 in the triple function hypoglycemic agent retatrutide
More general terms
More specific terms
Additional terms
- glucagon receptor; GL-R (GCGR)
- glucagon; contains: glicentin; glicentin-related polypeptide; GRPP; oxyntomodulin; OXM; OXY; glucagon-like peptide 1; GLP-1; glucagon-like peptide 1(7-37); GLP-1(7-37); glucagon-like peptide 1(7-36); GLP-1(7-36); glucagon-like peptide 2; GLP-2 (GCG)
References
- ↑ Zoler ML Triple Agonist Retatrutide Hits New Weight-Loss Highs. Medscape. June 26, 2023 https://www.medscape.com/viewarticle/993714
Jastreboff AM, Kaplan LM, Frias JP et al Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med. 2024. Jun 26. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37366315 https://www.nejm.org/doi/full/10.1056/NEJMoa2301972